Brind.

Seamus Mulligan bought shares of Jazz Pharmaceuticals on July 2, 2025.

1 report, 0 independent Updated Jul 2

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Jazz PharmaceuticalsSeamus Mulligan

Keep exploring

The entities involved

Jazz Pharmaceuticals
Irish tax-registered pharmaceutical corporation
- Jazz Pharmaceuticals plans U.S. launch of Ziihera.Wed 22:28
- Alan M. Sebulsky was appointed to the Board of Directors of MeiraGTx Holdings PLC, where he has previously served.Wed 13:55

Related events

Jazz Pharmaceuticals guaranteed notes issued by its subsidiary, Jazz Investments I Limited, on August 26, 2026.Aug 26

Coverage

Newest first; wire copies grouped

Jul 2Unknown outlet